CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUCH EXCLUDED INFORMATION HAS BEEN MARKED WITH “[***].Licence Agreement • October 21st, 2021 • Nuvectis Pharma, Inc. • Pharmaceutical preparations • England and Wales
Contract Type FiledOctober 21st, 2021 Company Industry Jurisdiction
LICENCE AGREEMENTLicence Agreement • October 6th, 2021 • Nuvectis Pharma, Inc. • Pharmaceutical preparations • England and Wales
Contract Type FiledOctober 6th, 2021 Company Industry Jurisdiction
LICENCE AGREEMENTLicence Agreement • September 20th, 2021 • Nuvectis Pharma, Inc. • Pharmaceutical preparations • England and Wales
Contract Type FiledSeptember 20th, 2021 Company Industry Jurisdiction